“…These were apparent on the physical examination in 22 patients, but, like others, we found imaging necessary to detect brachial plexus involvement in M0, no distant metastases other than axillary nodes c N0, no involved axillary nodes; N1, at least one axillary node; N2, matted axillary nodes d M1, metastases to distant sites, such as bone or lung, detectable by imaging e The supraclavicular and axillary regions were included in the radiation portal in 10 of the 13 patients who received primary radiation f Adjuvant or neoadjuvant chemotherapy, or initial chemotherapy for those patients who presented with metastatic disease g Long-term tamoxifen or anastrazole therapy; all these patients previously had chemotherapy h Months elapsing between original breast cancer presentation and fi rst evidence of brachial plexus syndrome a Narcotic analgesics not necessary to control pain b Narcotic analgesics necessary to control pain c Paresis relative to contralateral arm d Severe disability or complete paralysis e C5-6 Division involvement f C7-T1 Division involvement some patients. [11][12][13][14][15][16] In one patient computer-automated tomography, and in 4 magnetic resonance imaging (MRI) was necessary to demonstrate loco-regional metastases, including tumor within the brachial plexus. Two patients without loco-regional metastases developed pain and arm weakness 14 and 32 months after surgery and radiation.…”